Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
7.66
+0.24 (3.23%)
Apr 28, 2025, 9:32 AM EDT - Market open

Myriad Genetics Market Cap

Myriad Genetics has a market cap or net worth of $706.03 million as of April 28, 2025. Its market cap has decreased by -61.23% in one year.

Market Cap
706.03M
Enterprise Value
721.81M
1-Year Change
-61.23%
Ranking
Category
Stock Price
$7.66

Market Cap Chart

Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $706.03M, an increase of 590.16%. That is a compound annual growth rate of 7.59%.

History

DateMarket Cap% Change
Apr 25, 2025677.50M-45.72%
Dec 31, 20241.25B-20.67%
Dec 29, 20231.57B33.81%
Dec 30, 20221.18B-46.65%
Dec 31, 20212.20B48.19%
Dec 31, 20201.49B-26.57%
Dec 31, 20192.03B-6.80%
Dec 31, 20182.17B-8.61%
Dec 29, 20172.38B108.51%
Dec 30, 20161.14B-62.13%
Dec 31, 20153.01B21.14%
Dec 31, 20142.49B58.51%
Dec 31, 20131.57B-29.30%
Dec 31, 20122.22B25.03%
Dec 30, 20111.77B-15.91%
Dec 31, 20102.11B-15.93%
Dec 31, 20092.51B-18.54%
Dec 31, 20083.08B50.95%
Dec 31, 20072.04B64.00%
Dec 29, 20061.24B93.29%
Dec 30, 2005643.90M-6.71%
Dec 31, 2004690.20M98.11%
Dec 31, 2003348.40M-0.17%
Dec 31, 2002349.00M-71.84%
Dec 31, 20011.24B-34.15%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 794.31B
UnitedHealth Group 381.06B
Johnson & Johnson 371.93B
AbbVie 329.14B
Novo Nordisk 272.76B
Abbott Laboratories 223.47B
AstraZeneca 214.65B
Novartis AG 211.71B
Market Cap Rankings